MATTAWAN, June 18, 2007: As a global leader in preclinical research for the pharmaceutical and biotech industries, MPI Research will be active at the esteemed Japanese Society of Toxicology (JST) meeting being held at the Tower Hall Funabori in Tokyo, Japan on June 27-29, 2007. Along with its Japanese partner, LSG Corporation, MPI Research will be co-hosting a luncheon seminar on “Juvenile Toxicity Testing: When, Why, and How” on June 27th from 12:15 – 13:15 in Room 5, 2nd floor, in the conference center. Ali Faqi, DVM, PhD, DABT, Director of Developmental and Reproductive Toxicology at MPI Research, will be presenting the seminar. Dr. Faqi has held key positions in industry as well as academia, and has over 600 peer-reviewed papers published.

“JST is a prestigious meeting that provides a platform for knowledge-sharing by biotech and pharmaceutical thought leaders as well as networking opportunities among a body of international industry decision-makers,” says MPI Research’s Executive Vice President and Director of Research, James Laveglia, PhD. “As we become a stronger presence in the Asian market, we look forward to having high-level discussions with key players in Japan’s growing biopharmaceutical industry.”

MPI Research focuses on quality and timeliness in providing comprehensive preclinical research, from early proof of concept testing to regulatory submissions. Specific services include general toxicology, analytical and bioanalytical chemistry, safety pharmacology, surgical services, discovery pharmacokinetics, infusion toxicology, developmental and reproductive toxicology, drug metabolism and pharmacokinetics, pathology, targeted discovery research, immunotoxicology and immunogenicity, neurosciences, and molecular imaging. Because of increased demands for its scientific expertise and broad scope of services, MPI Research has systematically expanded its facilities and capabilities to maximize its ability to meet the needs of its Sponsors.

As an industry leader, MPI Research sponsors annual educational summits. This year’s summit, being held in Augusta, Michigan, USA August 15-17, 2007, focuses on preclinical cell-based therapy research.

MPI Research, with headquarters in Mattawan, Michigan, is one of the worlds leading providers of comprehensive preclinical research and development services. More information on the company’s services can be obtained through the website at www.mpiresearch.com.


Home | News